Welcome

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medication to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. Gilead’s primary therapeutic areas include HIV/AIDS, liver disease, invasive anti-fungal disease and serious cardiovascular and respiratory conditions. For more information please visit www.gilead.com.

Gilead’s Nordic affiliate was established 1st of July 2008 and assumes responsibility for Denmark, Sweden, Norway, Finland and Iceland. The Nordic headquarter is located in Solna, Sweden.

The Gilead Congress & Meetings Services is part of Gilead’s commitment to advance knowledge and care of life-threatening diseases. We look forward to welcome you to some of our events.